Adjuvant chemotherapy with or without an anthracycline in older adults with node-negative triple-negative breast cancer (TNBC): A SEER Medicare study.

被引：0
|
作者：
Schreiber, Anna R.
Kagihara, Jodi
Eguchi, Megan
Kabos, Peter
Meyer, Elisabeth
Kondapalli, Lavanya
Fisher, Christine M.
Bradley, Cathy J.
Diamond, Jennifer Robinson
机构：
[1] Univ Colorado, Aurora, CO USA
[2] Univ Colorado, Canc Ctr, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12505
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC).
    Steenbruggen, Tessa Gerjanne
    Van Ramshorst, Mette S.
    van Werkhoven, Erik
    Dezentje, Vincent O.
    Siesling, Sabine
    Linn, Sabine C.
    Sonke, Gabe S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
    Anna R. Schreiber
    Jodi Kagihara
    Megan Eguchi
    Peter Kabos
    Christine M. Fisher
    Elisabeth Meyer
    Elizabeth Molina
    Lavanya Kondapalli
    Cathy J. Bradley
    Jennifer R. Diamond
    Breast Cancer Research and Treatment, 2022, 191 : 389 - 399
  • [3] Adjuvant chemotherapy in small node-negative triple-negative breast cancer
    Steenbruggen, Tessa G.
    van Werkhoven, Erik
    van Ramshorst, Mette S.
    van Ramshorst, Mette S.
    Dezentje, Vincent O.
    Kok, Marleen
    Linn, Sabine C.
    Siesling, Sabine
    Sonke, Gabe S.
    EUROPEAN JOURNAL OF CANCER, 2020, 135 : 66 - 74
  • [4] Evaluating anthracycline plus taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study
    Schreiber, Anna R.
    Kagihara, Jodi
    Eguchi, Megan
    Kabos, Peter
    Fisher, Christine M.
    Meyer, Elisabeth
    Molina, Elizabeth
    Kondapalli, Lavanya
    Bradley, Cathy J.
    Diamond, Jennifer R.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 389 - 399
  • [5] Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER-Medicare study
    Roy, Savannah
    Lakritz, Stephanie
    Schreiber, Anna R.
    Molina, Elizabeth
    Kabos, Peter
    Wood, Marie
    Elias, Anthony
    Kondapalli, Lavanya
    Bradley, Cathy J.
    Diamond, Jennifer R.
    EUROPEAN JOURNAL OF CANCER, 2023, 185 : 69 - 82
  • [6] PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease
    Assaker, Gloria
    Camirand, Anne
    Abdulkarim, Bassam
    Omeroglu, Atilla
    Deschenes, Jean
    Joseph, Kurian
    Noman, Abu Shadat Mohammod
    Kumar, Agnihotram V. Ramana
    Kremer, Richard
    Sabri, Siham
    JNCI CANCER SPECTRUM, 2020, 4 (01)
  • [7] Association of Adjuvant Chemotherapy With Overall Survival Among Women With Small, Node-Negative, Triple-Negative Breast Cancer
    Oladeru, Oluwadamilola T.
    Singh, Anurag K.
    Ma, Sung Jun
    JAMA NETWORK OPEN, 2020, 3 (09)
  • [8] Major adverse cardiovascular event outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy in older adults with triple-negative breast cancer: A SEER-Medicare study
    Roy, S. C.
    Lakritz, S.
    Schreiber, A.
    Molina, E.
    Bradley, C.
    Kondapalli, L.
    Diamond, J. R.
    ANNALS OF ONCOLOGY, 2023, 34 : S326 - S326
  • [9] Survival Outcome and Impact of Chemotherapy in T1 Node-Negative Triple-Negative Breast Cancer: A SEER Database Analysis
    Zhang, Jingyi
    Wang, Wenna
    Wang, Jiayu
    Luo, Yang
    Chen, Shanshan
    Ma, Fei
    Xu, Binghe
    Fan, Ying
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [10] ADJUVANT CHEMOTHERAPY FOR NODE-NEGATIVE BREAST-CANCER
    SLEDGE, GW
    MCCASKILLSTEVENS, W
    CANCER INVESTIGATION, 1992, 10 (06) : 595 - 602
12345